Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0266601
Abstract: Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of 10%. A stagnant high mortality rate over the last decades highlights the need for innovative therapeutic approaches. Pancreatic tumors… read more here.
Keywords: metabolism; pancreatic cancer; cpi 613; targeting pancreatic ... See more keywords